05/29/2026
Training immune cells to find cancer -->
Researchers are testing a new type of treatment that “guides” immune cells directly to cancer cells.
One example is Tebentafusp, which:
- Directs T-cells to attack cancer cells more precisely
- Is already approved for another rare cancer
- Is now being tested in CCS clinical trials
👉 What this means: Instead of broadly stimulating the immune system, this therapy helps immune cells find the tumor more directly.
Read more here: https://www.clearcellsarcoma.org/research
Learn more about Phase II trial of Tebentafusp here: https://clinicaltrials.gov/study/NCT06942442?cond=Clear%20Cell%20Sarcoma&aggFilters=status:rec&rank=2